Another Hepatitis C Drug to come in the Market Soon
Hepatitis C has become one of the hottest categories in drug research as companies race to develop a combination therapy without injections and debilitating side effects. Some have had their promising candidates fail after extensive testing, due to dangerous side effects, but Gilead Sciences Inc is already raking in billions of dollars from its ground …
Another Hepatitis C Drug to come in the Market Soon Read More »
